Delivery Order SPE2DB22D3301-SPE2DB25FY8NC
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $33,751.91 to AmerisourceBergen Drug Corp for TREMFYA 100 mg/ml pharmaceutical product, with a completion date of July 25, 2025. This is a firm fixed price, non-set-aside contract awarded on July 24, 2025, with performance to be executed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was competitively selected to...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,255.25 to AmerisourceBergen Drug Corp for TREMFYA 100 MG/ML, a pharmaceutical product, with a completion date of July 31, 2025. This non-set-aside, competitively awarded contract reflects a firm fixed price arrangement typical of the agency's medical supply procurement practices. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order at...
- The Defense Logistics Agency awarded a delivery order valued at $14,691.41 to AmerisourceBergen Drug Corp for TREMFYA 100 MG/ML, a prescription pharmaceutical product. The contract, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, utilizes firm fixed pricing and carries no set-aside designation, indicating it was competitively awarded. Performance will occur at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $43,531.56 to AmerisourceBergen Drug Corp for TREMFYA 100 MG/ML, a pharmaceutical product, with an ultimate completion date of August 1, 2025. This firm fixed price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,401.76 to AmerisourceBergen Drug Corp for TREMFYA 100 mg/mL, a pharmaceutical product, with an ultimate completion date of August 4, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The work will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $8,962.95 to AmerisourceBergen Drug Corp for the supply of TREMFYA 200 mg/20 mL vials. This non-set-aside, competitively awarded contract represents a firm fixed price delivery order with an ultimate completion date of August 20, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor...
- The Defense Logistics Agency awarded a delivery order valued at $21,941.27 to AmerisourceBergen Drug Corp for TREMFYA 100 mg/ml pharmaceutical supply on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed-price delivery order represents a non-competitive set-aside contract and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $14,972.27 on July 31, 2025, by the Defense Logistics Agency for TREMFYA 100 mg/ml, a pharmaceutical product used in the treatment of immunological conditions. The contract is structured as a firm fixed price delivery order with an ultimate completion date of August 1, 2025, and carries no set-aside designation, indicating it was competitively...
- The Defense Logistics Agency awarded a delivery order valued at $7,255.25 to AmerisourceBergen Drug Corp for TREMFYA 200 mg/2 mL pen (2 mL), a pharmaceutical product for military and federal healthcare use. This non-set-aside, competitively awarded contract carries a firm fixed price structure and is scheduled for completion by July 24, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and is registered in the System for Award Management...
- The U.S. Defense Logistics Agency (DLA) awarded a $27,203.88 firm-fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office division. The order is for the supply of TREMFYA 100 MG/ML INJECTORML pharmaceutical products. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables DLA Troop Support Medical to efficiently procure a comprehensive range of pharmaceutical and medical supplies from...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FY8NCDelivery Order
The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $60,584.28 for TREMFYA 100 mg/ml pharmaceutical product, with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the vendor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, is fulfilling this delivery order as a child contract under its larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical. This delivery order is issued under AmerisourceBergen Drug Corp's comprehensive $999,999,999.00 Pharmaceutical Prime Vendor Global IDC (SPE2DX) with the DLA, which runs through December 2026 and supports military healthcare programs worldwide. The broader contract vehicle enables the company to supply an extensive range of pharmaceutical products, medical supplies, vaccines, and specialty medications to Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. AmerisourceBergen's demonstrated capability to compete successfully for federal medical procurement across multiple therapeutic domains and delivery formats, combined with its significant prime vendor status, positions it as a key supplier within the DLA's medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $60.6k | 7/29/25 |